Press Releases
September 1, 2026
AI/ML Innovations subsidiary NeuralCloud Appoints Former FDA Reviewer Dr. Mehmet Kosoglu as the Head of Regulatory Affairs
August 18, 2026
AIML Subsidiary NeuralCloud Signs Term Sheet with Island Mobile Cardiology Testing for CardioYield™ Pilot
August 11, 2026
AI/ML Innovations’ Subsidiary NeuralCloud Achieves ISO 13485:2016 (MDSAP) Certification
June 23, 2026
AI/ML Innovations Inc. Announces Grant of U.S. Patent Expanding Protection for AI-Driven ECG Analysis
June 1, 2026
AIML Subsidiary NeuralCloud Appoints Cardiac Monitoring Veterans Dale and Nicholas DuBois to Lead Clinical and Overread Operations
March 31, 2026
Neural Cloud Signs Reseller Agreement with European Digital Cardiac Monitoring Platform
March 27, 2026
AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000
March 25, 2026
AIML Subsidiary NeuralCloud Enters Research Services Agreement with Baker Heart and Diabetes Institute to Support AI-Driven ECG Analysis
March 12, 2026
AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures
February 24, 2026
Neural Cloud Enters Distribution Agreement with Intelimed to Expand into Latin America
February 12, 2026
AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting
February 10, 2026
Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion
January 28, 2026
AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board
January 20, 2026
AIML subsidiary NeuralCloud Collaborates with Movesense to Expand Bundled ECG Solutions for Clinical and Wellness Markets
January 8, 2026
AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield™ for AI-Powered Holter Analysis
January 7, 2026
AIML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale
December 30, 2025
AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer
December 9, 2025
AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield™ and Insight360™ into INTRINSICA's DNA-Guided Biofeedback Wellness Ecosystem
December 2, 2025
AIML subsidiary NeuralCloud Enters Pilot with Cornerstone Physiotherapy to Deploy MaxYield™ and Insight360™ for Elite Athlete Cardiac Performance Testing
November 26, 2025
AIML subsidiary NeuralCloud Signs Commercial Term Sheet with Equimetrics to Deploy MaxYield™ and CardioYield™ across Equine Cardiac Monitoring Platforms
November 24, 2025
AIML subsidiary Neural Cloud begins pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care